支架血栓症:定义,风险因素和管理的当代指南
Ambre Flowers1, Bernard Evenhuis1, Benjamin Gabanic1
1Department of Internal Medicine, Emory University, Atlanta, GA, United States.
Frontiers in cardiovascular medicine
|November 6, 2025
概括
支架血栓症是穿皮冠状动脉干预的严重并发症,影响约0.5%的病例. 本综述涵盖了其类型,原因和管理,以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 生物医学工程 生物医学工程
背景情况:
- 支架血栓是通过皮肤冠状动脉干预 (PCI) 后的一个重大并发症.
- 尽管有进展,但确定的或可能的支架血栓发生在~0.5%的PCI病例中,带来了相当大的发病率和死亡率.
- 亚急性和非常晚期支架血栓是最常见的类型.
研究的目的:
- 审查定义,分类,病理生理学和支架血栓形成的危险因素.
- 讨论目前的预防和管理策略.
- 检查支架技术和药理干预的进展.
主要方法:
- 关于支架血栓形成的文献综述.
- 对真实世界的注册数据分析关于支架血栓发生率和结果.
- 探索临床后果,风险因素和患者特征.
- 检查程序变量和病变复杂性.
- 复发性支架血栓瘤问题的审查.
主要成果:
- 支架血栓发生在大约0.5%的PCI病例中.
- 30天死亡率接近25%,10年后的长期风险超过30%.
- 最常见的是亚急性和非常晚期的支架血栓形成.
- 临床后果包括心肌梗塞,新兴的再血管化和心血管风险增加.
结论:
- 支架血栓形成需要及时识别和干预.
- 多学科的方法对于减轻支架血栓发生率至关重要.
- 支架技术和药物治疗的持续进步对于改善患者的治疗结果至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
271
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
271
Venous Thrombosis I: Introduction
334
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
334
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
293
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
293
Pulmonary Embolism III: Nursing Management
343
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
343
Venous Thrombosis IV: Nursing Management
190
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
190
Atherosclerosis III: Management
307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307


